US Bancorp DE raised its position in shares of National Health Investors, Inc. (NYSE:NHI) by 0.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,836 shares of the real estate investment trust’s stock after buying an additional 44 shares during the period. US Bancorp DE’s holdings in National Health Investors were worth $700,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Teachers Advisors LLC increased its position in National Health Investors by 3.7% in the fourth quarter. Teachers Advisors LLC now owns 61,777 shares of the real estate investment trust’s stock worth $4,582,000 after buying an additional 2,199 shares during the period. Doyle Wealth Management purchased a new position in National Health Investors during the first quarter worth $227,000. Nisa Investment Advisors LLC increased its position in National Health Investors by 2.2% in the first quarter. Nisa Investment Advisors LLC now owns 24,000 shares of the real estate investment trust’s stock worth $1,743,000 after buying an additional 525 shares during the period. State of Alaska Department of Revenue increased its position in National Health Investors by 29.5% in the first quarter. State of Alaska Department of Revenue now owns 19,030 shares of the real estate investment trust’s stock worth $1,381,000 after buying an additional 4,330 shares during the period. Finally, Navellier & Associates Inc increased its position in National Health Investors by 7.3% in the first quarter. Navellier & Associates Inc now owns 5,487 shares of the real estate investment trust’s stock worth $399,000 after buying an additional 371 shares during the period. 69.10% of the stock is currently owned by institutional investors.

Shares of National Health Investors, Inc. (NHI) traded up 0.99% during mid-day trading on Monday, hitting $77.30. The stock had a trading volume of 57,076 shares. The firm has a market cap of $3.17 billion, a PE ratio of 19.85 and a beta of 0.56. The stock’s 50-day moving average price is $77.38 and its 200-day moving average price is $75.03. National Health Investors, Inc. has a 52-week low of $66.31 and a 52-week high of $82.53.

National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by $0.36. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business had revenue of $69.84 million for the quarter, compared to analysts’ expectations of $67.68 million. During the same quarter in the previous year, the business posted $1.22 earnings per share. National Health Investors’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, analysts anticipate that National Health Investors, Inc. will post $3.79 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.95 per share. The ex-dividend date is Thursday, September 28th. This represents a $3.80 annualized dividend and a dividend yield of 4.96%. National Health Investors’s payout ratio is 97.69%.

ILLEGAL ACTIVITY NOTICE: “National Health Investors, Inc. (NYSE:NHI) Position Raised by US Bancorp DE” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/14/national-health-investors-inc-nysenhi-position-raised-by-us-bancorp-de.html.

A number of research firms recently weighed in on NHI. BidaskClub raised National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, June 29th. Mizuho reaffirmed a “neutral” rating on shares of National Health Investors in a research note on Wednesday, June 28th. Stifel Nicolaus upped their price target on National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Wednesday, June 21st. Zacks Investment Research downgraded National Health Investors from a “buy” rating to a “sell” rating in a research note on Tuesday, July 18th. Finally, ValuEngine downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $79.60.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.